Sophia Ibrahimi
Swanson Hall was created as a place to save lives. Its demise will lay the groundwork to save even more.
Sep 17, 2013
Holland Regenerative Medicine Program promotes innovative research
Regenerative medicine – a research area that will dramatically impact health and change disease outcomes – got a big boost at UNMC with a gift from Mary and Dick Holland.
Sep 17, 2013
Health policy expert is in the house
A minimalist by nature, Jim Stimpson, Ph.D., occupies an office with no papers on the desk, no pictures on the walls.
Sep 17, 2013
UNMC’s emergency department research director, who died in 2012, planned to return to his native Vietnam to teach the U.S. approach to graduate medical education. He was going to improve patient care through better education in the region where he was born. He was going to make a difference.
Sep 17, 2013
See one, do one, teach one? Not anymore.
Instruction of the next generation of surgeons just became more high-tech with the June opening of the Dr. Wayne and Eileen Ryan Surgical Simulation Suite.
Sep 17, 2013
Antidepressants reduce depression in head and neck cancer patients
UNMC study could change guidelines for treating these cancers.
Sep 17, 2013
Medical student has roots in Nebraska soil
Over hours on a tractor, the stress and strife of med school seem to melt away. Some have their bubble bath. He has his alfalfa patch.
Sep 17, 2013
Innovative eye treatments the goal at new institute
The new Stanley M. Truhlsen Eye Institute will be the center of translational research and clinical trials for eye diseases.
Sep 17, 2013
Power Wheels to Makeshift Power Wheelchairs
The idea to modify cars is not new. Just look at reality shows like “Trick My Truck.”
But the concept of adapting toy cars for children with disabilities? Now, that’s novel.
Sep 17, 2013
The following industry-sponsored contracts have been received. Here is more information on clinical trials enrolling patients at UNMC. James Gigantelli, M.D., ophthalmology and visual sciences, is the UNMC lead for a multi-center Phase III clinical trial to evaluate the safety and effectiveness of a novel protein therapy for the treatment of thyroid eye disease (TED). […]
Sep 5, 2013